Carlo Tascini

About Carlo Tascini

Carlo Tascini, With an exceptional h-index of 50 and a recent h-index of 38 (since 2020), a distinguished researcher at Università degli Studi di Udine, specializes in the field of Bacterial and fungal infection.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia

Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study

In vivo evolution to high-level cefiderocol resistance of NDM-1–producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

MAGLIO study: epidemiological analysis on invasive meningococcal disease in Italy: focus on hospitalization from 2015 to 2019—reply

COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa

Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23

Carlo Tascini Information

University

Position

Infectious diseases

Citations(all)

9795

Citations(since 2020)

6411

Cited By

5274

hIndex(all)

50

hIndex(since 2020)

38

i10Index(all)

172

i10Index(since 2020)

132

Email

University Profile Page

Google Scholar

Carlo Tascini Skills & Research Interests

Bacterial and fungal infection

Top articles of Carlo Tascini

Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia

PHUPONG Vorapong

2024/1

Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study

Journal of Global Antimicrobial Resistance

2024/3/1

In vivo evolution to high-level cefiderocol resistance of NDM-1–producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission

Clinical Microbiology and Infection

2024/3/1

MAGLIO study: epidemiological analysis on invasive meningococcal disease in Italy: focus on hospitalization from 2015 to 2019—reply

Internal and Emergency Medicine

2024/2/20

Carlo Tascini
Carlo Tascini

H-Index: 29

COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes

Irish Journal of Psychological Medicine

2024/2/14

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa

Journal of Global Antimicrobial Resistance

2024/2/6

Carlo Tascini
Carlo Tascini

H-Index: 29

Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23

Journal of Anesthesia, Analgesia and Critical Care

2024/12

Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort

Liver International

2024/2

The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way

2024/1/29

Maximally informative feature selection using Information Imbalance: Application to COVID-19 severity prediction

arXiv preprint arXiv:2404.14275

2024/4/22

Carlo Tascini
Carlo Tascini

H-Index: 29

Alessandro Laio
Alessandro Laio

H-Index: 35

Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19

Clinical Microbiology and Infection

2024/4/1

A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid

Heliyon

2024/3/30

Luca Montanari
Luca Montanari

H-Index: 5

Carlo Tascini
Carlo Tascini

H-Index: 29

Revolutionizing Daptomycin Dosing: A Single 7–11-Hour Sample for Pragmatic Application

Clinical Infectious Diseases

2024/3/29

Shuhan Liu
Shuhan Liu

H-Index: 4

Carlo Tascini
Carlo Tascini

H-Index: 29

An Aminoglycoside-Sparing Regimen with Double Beta-Lactam to Successfully Treat Granulicatella adiacens Prosthetic Aortic Valve Endocarditis—Time to …

Infectious Disease Reports

2024/3/14

Floriana Campanile
Floriana Campanile

H-Index: 17

Carlo Tascini
Carlo Tascini

H-Index: 29

Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the …

The Lancet Regional Health–Europe

2023/8/1

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

Journal of Hematology & Oncology

2023/4/1

See List of Professors in Carlo Tascini University(Università degli Studi di Udine)